TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma

SIMPLE SUMMARY: Most patients with glioblastoma (GBM) develop recurrent diseases which can be treated with different approaches. Given the aggressive and resilient nature of GBM, continued efforts to better understand GBM pathophysiology are required to discover novel targets for future therapy. The...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancers (Basel)
Main Authors: Campolo, Michela, Lanza, Marika, Casili, Giovanna, Paterniti, Irene, Filippone, Alessia, Caffo, Maria, Cardali, Salvatore M., Puliafito, Ivana, Colarossi, Cristina, Raciti, Gabriele, Cuzzocrea, Salvatore, Esposito, Emanuela
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7794959/
https://ncbi.nlm.nih.gov/pubmed/33375627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010041
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker